IRLAB to Present at BioStock Life Science Summit 2024

Gothenburg, Sweden, November 13, 2024 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company that discovers and develops new treatments for Parkinson’s disease, today announces that CEO Kristina Torfgård will present IRLAB to potential partners and specialist investors in life science at the seventh edition of BioStock Life Science Summit. The event will take place on November 20-21 in Lund, Sweden.

IRLAB publishes interim report for the period January – September 2024

IRLAB reports continued progress ahead of the mesdopetam Phase III program